These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 28031537)

  • 1. Activation of ATR-Chk1 pathway facilitates EBV-mediated transformation of primary tonsillar B-cells.
    Mordasini V; Ueda S; Aslandogmus R; Berger C; Gysin C; Hühn D; Sartori AA; Bernasconi M; Nadal D
    Oncotarget; 2017 Jan; 8(4):6461-6474. PubMed ID: 28031537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STAT3 interrupts ATR-Chk1 signaling to allow oncovirus-mediated cell proliferation.
    Koganti S; Hui-Yuen J; McAllister S; Gardner B; Grasser F; Palendira U; Tangye SG; Freeman AF; Bhaduri-McIntosh S
    Proc Natl Acad Sci U S A; 2014 Apr; 111(13):4946-51. PubMed ID: 24639502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tonsillar CD56brightNKG2A+ NK cells restrict primary Epstein-Barr virus infection in B cells via IFN-γ.
    Jud A; Kotur M; Berger C; Gysin C; Nadal D; Lünemann A
    Oncotarget; 2017 Jan; 8(4):6130-6141. PubMed ID: 28008151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marek's Disease Virus Disables the ATR-Chk1 Pathway by Activating STAT3.
    Lian X; Bao C; Li X; Zhang X; Chen H; Jung YS; Qian Y
    J Virol; 2019 May; 93(9):. PubMed ID: 30787154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An ATM/Chk2-mediated DNA damage-responsive signaling pathway suppresses Epstein-Barr virus transformation of primary human B cells.
    Nikitin PA; Yan CM; Forte E; Bocedi A; Tourigny JP; White RE; Allday MJ; Patel A; Dave SS; Kim W; Hu K; Guo J; Tainter D; Rusyn E; Luftig MA
    Cell Host Microbe; 2010 Dec; 8(6):510-22. PubMed ID: 21147465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr Virus Hijacks DNA Damage Response Transducers to Orchestrate Its Life Cycle.
    Hau PM; Tsao SW
    Viruses; 2017 Nov; 9(11):. PubMed ID: 29144413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olaparib-induced Apoptosis Through EBNA1-ATR-p38 MAPK Signaling Pathway in Epstein-Barr Virus-positive Gastric Cancer Cells.
    Moon SH; Park NS; Noh MH; Kim YS; Cheong SH; Hur DY
    Anticancer Res; 2022 Jan; 42(1):555-563. PubMed ID: 34969765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary CD4+ T-cell responses provide both helper and cytotoxic functions during Epstein-Barr virus infection and transformation of fetal cord blood B cells.
    MacArthur GJ; Wilson AD; Birchall MA; Morgan AJ
    J Virol; 2007 May; 81(9):4766-75. PubMed ID: 17314172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus infection negatively impacts the CXCR4-dependent migration of tonsillar B cells.
    Ehlin-Henriksson B; Mowafi F; Klein G; Nilsson A
    Immunology; 2006 Mar; 117(3):379-85. PubMed ID: 16476057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-stimulation of CD81 expression by resting B cells increases proliferation following EBV infection, but the overexpression of CD81 induces the apoptosis of EBV-transformed B cells.
    Park GB; Kim D; Park SJ; Lee HK; Kim JH; Kim YS; Park SG; Choi IH; Yoon SH; Lee YJ; Paeng S; Hur DY
    Int J Mol Med; 2015 Dec; 36(6):1464-78. PubMed ID: 26498453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Epstein-Barr virus nuclear antigen-1 upregulates the cellular antioxidant defense to enable B-cell growth transformation and immortalization.
    Wang J; Nagy N; Masucci MG
    Oncogene; 2020 Jan; 39(3):603-616. PubMed ID: 31511648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissecting the contribution of EBNA3C domains important for EBV-induced B-cell growth and proliferation.
    Jha HC; Shukla SK; Lu J; Aj MP; Banerjee S; Robertson ES
    Oncotarget; 2015 Oct; 6(30):30115-29. PubMed ID: 26336822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr Virus (EBV)-Related Lymphoproliferative Disorders in Ataxia Telangiectasia: Does ATM Regulate EBV Life Cycle?
    Tatfi M; Hermine O; Suarez F
    Front Immunol; 2018; 9():3060. PubMed ID: 30662441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p62-mediated Selective autophagy endows virus-transformed cells with insusceptibility to DNA damage under oxidative stress.
    Wang L; Howell MEA; Sparks-Wallace A; Hawkins C; Nicksic CA; Kohne C; Hall KH; Moorman JP; Yao ZQ; Ning S
    PLoS Pathog; 2019 Apr; 15(4):e1007541. PubMed ID: 31017975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress enables Epstein-Barr virus-induced B-cell transformation by posttranscriptional regulation of viral and cellular growth-promoting factors.
    Chen X; Kamranvar SA; Masucci MG
    Oncogene; 2016 Jul; 35(29):3807-16. PubMed ID: 26592445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examining the dynamics of Epstein-Barr virus shedding in the tonsils and the impact of HIV-1 coinfection on daily saliva viral loads.
    Byrne CM; Johnston C; Orem J; Okuku F; Huang ML; Rahman H; Wald A; Corey L; Schiffer JT; Casper C; Coombs D; Gantt S
    PLoS Comput Biol; 2021 Jun; 17(6):e1009072. PubMed ID: 34153032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human B cells on their route to latent infection--early but transient expression of lytic genes of Epstein-Barr virus.
    Kalla M; Hammerschmidt W
    Eur J Cell Biol; 2012 Jan; 91(1):65-9. PubMed ID: 21450364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Latent gammaherpesvirus exacerbates arthritis through modification of age-associated B cells.
    Mouat IC; Morse ZJ; Shanina I; Brown KL; Horwitz MS
    Elife; 2021 Jun; 10():. PubMed ID: 34080972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of Epstein-Barr virus infection models in a series of pediatric carriers from a developing country.
    Vistarop AG; Cohen M; De Matteo E; Preciado MV; Chabay PA
    Sci Rep; 2016 Mar; 6():23303. PubMed ID: 26988293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression profile of Epstein-Barr virus and human adenovirus small RNAs in tonsillar B and T lymphocytes.
    Assadian F; Kamel W; Laurell G; Svensson C; Punga T; Akusjärvi G
    PLoS One; 2017; 12(5):e0177275. PubMed ID: 28542273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.